Is TRAIL hepatotoxic?
Gores
G J
GJ
Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic, and Foundation, Rochester, MN 55905, USA. gores.gregory@mayo.edu
Kaufmann
S H
SH
D000818:Animals; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins; D002462:Cell Membrane / Q000737:chemistry; D022781:Hepatocytes / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008107:Liver Diseases / Q000209:etiology* / Q000473:pathology; D008562:Membrane Glycoproteins / Q000009:adverse effects* / Q000737:chemistry / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor / Q000032:analysis / Q000502:physiology; D015398:Signal Transduction; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects* / Q000737:chemistry / Q000502:physiology
D051017:Apoptosis Regulatory Proteins; D008562:Membrane Glycoproteins; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D018124:Receptors, Tumor Necrosis Factor; D053221:TNF-Related Apoptosis-Inducing Ligand; C105190:TNFRSF10A protein, human; C505639:TNFRSF10B protein, human; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha